Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model, Statistics in Medicine, vol.60, issue.14, pp.1940-1956, 2009. ,
DOI : 10.1111/j.0006-341X.2004.00148.x
URL : https://hal.archives-ouvertes.fr/inserm-00371363
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0, Computer Methods and Programs in Biomedicine, vol.98, issue.1, pp.55-65, 2010. ,
DOI : 10.1016/j.cmpb.2009.09.012
URL : https://hal.archives-ouvertes.fr/inserm-00431457
Using Modelling & Simulation techniques to optimise the design of a paediatric PK/PD study, Population Approach Group in Europe, 2010. ,
Mathematical expressions of the pharmacokinetic and pharmacodynamic models implemented in the PFIM software ,
Practical Identifiability of HIV Dynamics Models, Bulletin of Mathematical Biology, vol.48, issue.8, pp.2493-2513, 2007. ,
DOI : 10.1007/s11538-007-9228-7
URL : https://hal.archives-ouvertes.fr/inserm-00204273
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic???pharmacodynamic models, Computer Methods and Programs in Biomedicine, vol.86, issue.1, pp.51-61, 2007. ,
DOI : 10.1016/j.cmpb.2007.01.004
Simultaneous population optimal design for pharmacokineticpharmacodynamic experiments, American Association of Pharmaceutical Scientists Journal, vol.7, issue.4, pp.759-785, 2005. ,
Population-based ADME Simulator, Expert Opinion on Drug Metabolism & Toxicology, vol.45, issue.2, pp.211-223, 2009. ,
DOI : 10.1080/00498250701620726
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children, Clinical Pharmacokinetics, vol.45, issue.9, pp.931-956, 2006. ,
Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, pp.429-442, 1997. ,
DOI : 10.1093/biomet/84.2.429
Comparison of results of the different software for design evaluation in population pharmacokinetics and pharmacodynamics, Population Approach Group in Europe, 2011. ,
Some Considerations on the Fisher Information in Nonlinear Mixed Effects Models, Proceedings of the 9th International Workshop in Model-Oriented Design and Analysis, 2010. ,
DOI : 10.1007/978-3-7908-2410-0_17
Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models, Statistics in Medicine, vol.30, issue.11-12, 2011. ,
DOI : 10.1002/sim.4191
URL : https://hal.archives-ouvertes.fr/inserm-00629594
Simultaneous optimal experimental design on dose and sample times, Journal of Pharmacokinetics and Pharmacodynamics, vol.17, issue.5, pp.125-145, 2009. ,
DOI : 10.1007/s10928-009-9114-z
Different approximations and methods for calculating the FIM and their consequences, Population Optimum Design of Experiments, 2008. ,
Incorporating Correlation in Interindividual Variability for the Optimal Design of Multiresponse Pharmacokinetic Experiments, Journal of Biopharmaceutical Statistics, vol.12, issue.2, pp.342-358, 2008. ,
DOI : 10.1007/s10928-005-0026-2
Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling, Clinical Pharmacokinetics, vol.283, issue.10, pp.239-258, 2010. ,
DOI : 10.2165/11318130-000000000-00000
Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs, Computer Methods and Programs in Biomedicine, vol.65, issue.2, pp.141-151, 2001. ,
DOI : 10.1016/S0169-2607(00)00117-6
Design in nonlinear mixed effects models: Optimization using the Fedorov???Wynn algorithm and power of the Wald test for binary covariates, Statistics in Medicine, vol.39, issue.28, pp.5162-5179, 2007. ,
DOI : 10.1002/sim.2910
URL : https://hal.archives-ouvertes.fr/hal-00263513
Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.13, issue.2, pp.209-227, 2003. ,
DOI : 10.1081/BIP-100101009
Extension of the SAEM algorithm to left-censored data in non- Figure 3: Influence of covariance on SE (left, ) and RSE (right, ?) of covariance for the single-response model (top), and influence of covariance on criterion for the single-response model (bottom) ,